(C) Immunoprecipitation of the endogenous Squ from ovarian lysate revealed the interaction with Spn-E protein. Proteins were detected by western blotting analysis using the specific antibody for each ...
Thermo Fisher (TMO) announced that its board of directors has authorized the repurchase of $4B of shares of its common stock in the open market ...
The global gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2 ...
WALTHAM, Mass., November 15, 2024--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the ...
Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
Thermo Fisher Scientific Inc. ( NYSE:TMO ) shareholders might be concerned after seeing the share price drop 10% in ...
Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...
Report on how AI is driving market transformation - The global DNA sequencing market size is estimated to grow by USD 17.34 ...
Thermo Fisher Scientific Inc. is one of the leading providers of medical equipment, analytical instruments, reagents & consumables, software, and services. Through its Life Science Solutions segment, ...
Key Players: Prominent market players include Bio-Rad Laboratories, Chembio Diagnostics, Enfer, IDEXX Laboratories, IDVet, LIONEX, PBD Biotech, QIAGEN, Thermo Fisher Scientific, and ZENDAL. These ...